BioLineRx (BLRX) EV to FCF (2015 - 2026)
Powered by 
Analysis
BioLineRx (BLRX) EV to FCF (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | BioLineRx | 6.46 Bn | 6.46 Bn | 235,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,528.91 |
| Mar 31, 2026 | -2,634.86 |
| Dec 31, 2025 | -2,255.07 |
| Sep 30, 2025 | -2,146.22 |
| Jun 30, 2025 | -30,775.11 |
| Mar 31, 2025 | -1,358.56 |
| Dec 31, 2024 | -1,165.80 |
| Sep 30, 2024 | -2,385.87 |
| Jun 30, 2024 | -2,188.48 |
| Mar 31, 2024 | -3,456.06 |
| Dec 31, 2023 | 13,619.89 |
| Sep 30, 2023 | -6,784.39 |
| Jun 30, 2023 | -6,140.05 |
| Mar 31, 2023 | -4,109.98 |
| Dec 31, 2022 | -3,756.40 |
| Sep 30, 2022 | -3,061.88 |
| Jun 30, 2022 | -5,856.34 |
| Mar 31, 2022 | -8,776.24 |
| Dec 31, 2021 | -10,714.87 |
| Sep 30, 2021 | -5,532.43 |